From February 5, 2024 to March 31, 2024, the company has repurchased 10,018,000 shares, representing 2.09% for CNY 148.61 million. With this, the company has completed the repurchase of 10,018,000 shares, representing 2.09% for CNY 148.61 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.79 CNY | -2.44% | -2.95% | -14.21% |
23/05 | Foyou Pharmaceutical Gets Nod to Market Valproic Acid | MT |
23/04 | Beijing Foyou Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-14.21% | 96Cr | |
+42.60% | 75TCr | |
+32.79% | 60TCr | |
-5.74% | 36TCr | |
+17.79% | 33TCr | |
+3.37% | 28TCr | |
+17.19% | 24TCr | |
+9.25% | 21TCr | |
-3.89% | 21TCr | |
+1.81% | 17TCr |
- Stock Market
- Equities
- 601089 Stock
- News Beijing Foyou Pharma CO.,LTD
- Tranche Update on Beijing Foyou Pharma CO.,LTD's Equity Buyback Plan announced on February 6, 2024.